| scholarly article | Q13442814 |
| P50 | author | Jon A Kobashigawa | Q64877043 |
| P2093 | author name string | Michael C Fishbein | |
| Abbas Ardehali | |||
| Ping Ge | |||
| David W Gjertson | |||
| Marlene L Rose | |||
| Elaine F Reed | |||
| Qiuheng Zhang | |||
| Jignesh K Patel | |||
| J Michael Cecka | |||
| P2860 | cites work | Renal allograft failure and antibodies to epithelial cells | Q67515235 |
| Anti-endothelial antibodies and coronary artery disease after cardiac transplantation | Q67517643 | ||
| Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis | Q73041731 | ||
| Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients | Q73128653 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection | Q73832055 | ||
| Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss | Q80225059 | ||
| Antibodies against MICA antigens and kidney-transplant rejection | Q81357717 | ||
| Lack of effect of MICA antibodies on graft survival following heart transplantation | Q84139772 | ||
| Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy | Q33318685 | ||
| Humoral theory of transplantation | Q35142603 | ||
| Effect of antibodies on endothelium | Q35547335 | ||
| Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. | Q35691658 | ||
| Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection | Q36034003 | ||
| Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection | Q36317528 | ||
| Acute antibody-mediated rejection following heart transplantation | Q36872090 | ||
| Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures | Q37132842 | ||
| The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. | Q40131011 | ||
| Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure | Q40386334 | ||
| MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies | Q40742227 | ||
| Antibodies against Donor Antigens on Endothelial Cells and Monocytes in Eluates of Rejected Kidney Allografts | Q41484690 | ||
| Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids | Q42511341 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation | Q46077973 | ||
| Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. | Q46126109 | ||
| RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells | Q46386272 | ||
| Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. | Q50674616 | ||
| Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. | Q53243295 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1153-1158 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | HLA and MICA: targets of antibody-mediated rejection in heart transplantation | |
| P478 | volume | 91 |
| Q40331013 | AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation |
| Q46456694 | Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies |
| Q38215262 | Acute and chronic antibody-mediated rejection in pediatric kidney transplantation |
| Q26766411 | Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen |
| Q41849097 | Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. |
| Q28076193 | Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation |
| Q36160309 | Assessment of Immunological Biomarkers in the First Year after Heart Transplantation |
| Q39128537 | Biomarkers of acute rejection following cardiac transplantation. |
| Q36584512 | Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo |
| Q35244151 | Cardiac allograft vasculopathy: a donor or recipient induced pathology? |
| Q90418489 | Discovery of Non-HLA Antibodies Associated with Cardiac Allograft Rejection and Development and Validation of a Non-HLA Antigen Multiplex Panel: from Bench to Bedside |
| Q28069956 | Genetic barriers in transplantation medicine |
| Q89425395 | HLA and lung transplantation |
| Q37430871 | HLA class I antibody-mediated endothelial and smooth muscle cell activation |
| Q36360674 | HLA class I: an unexpected role in integrin β4 signaling in endothelial cells |
| Q39121365 | Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection |
| Q38110566 | Immune responses to self-antigens (autoimmunity) in allograft rejection |
| Q39268286 | Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation |
| Q92033719 | Impact of pretransplant antibodies on outcomes after heart transplantation |
| Q38670363 | Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients. |
| Q36880424 | MICA variant promotes allosensitization after kidney transplantation |
| Q39178552 | Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation |
| Q48165787 | Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection. |
| Q38123310 | Moving beyond HLA: a review of nHLA antibodies in organ transplantation |
| Q39217968 | Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection |
| Q37426021 | Pathologic findings in lung allografts with anti-HLA antibodies |
| Q40159121 | Postanastomotic transplant renal artery stenosis: association with de novo class II donor-specific antibodies. |
| Q59314345 | Precision Diagnostics in Transplantation: From Bench to Bedside |
| Q38019584 | Prediction of organ transplant rejection by HLA-specific and non-HLA antibodies--brief literature review |
| Q41974861 | Role of MICA expression, anti-MICA antibodies and serum MICA during acute rejection in a rat-to-mouse cardiac transplantation model |
| Q38025804 | Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications |
| Q48774892 | State-of-the-Art in Tissue-Engineered Heart Repair |
| Q86635362 | The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes |
| Q38877375 | The importance of non-HLA antibodies in transplantation |
| Q89148849 | Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients |
| Q28069336 | Unraveling the Role of Allo-Antibodies and Transplant Injury |
Search more.